期刊文献+

生存素反义寡核苷酸对乳腺癌MCF-7细胞株MMP-2及MMP-9表达的影响 被引量:5

Effect of survivin ASODN transfection on the expression of MMP-2 and MMP-9 in human breast cancer cell
下载PDF
导出
摘要 目的:研究生存素(survivin)反义寡核苷酸(antisense oligodeoxynucleotide,ASODN)对人乳腺癌MCF-7细胞株基质金属蛋白酶(matrix metalloproteinase,MMP)-2及MMP-9表达的影响,以进一步阐明生存素介导乳腺癌浸润及转移的机制。方法:经脂质体介导将生存素ASODN转染人乳腺癌细胞株MCF-7,用荧光显微镜检测转染效率,用逆转录聚合酶链反应(RT-PCR)、蛋白质印迹法检测转染细胞生存素、MMP-2及MMP-9表达改变。结果:荧光显微镜检测结果显示生存素ASODN可成功转染MCF-7细胞。与空脂质体组、空ASODN组相比,转染组细胞生存素、MMP-2、MMP-9 mRNA和蛋白的表达均显著降低。结论:生存素ASODN转染可有效抑制MCF-7细胞生存素基因的表达,并降低其MMP-2、MMP-9表达,可能对乳腺癌具有基因治疗的效果。 Objective: To investigate the effect of survivin antisense oligodeoxynucleotide(ASODN) transfection on the expression of matrix metalloproteinase(MMP)-2 and MMP-9 in human breast cancer line MCF-7 and to provide experimental foundation for survivin ASODN gene therapy for breast cancer.Methods: Survivin ASODN was transfected into MCF-7 cells through lipofectin.The rate of transfection was detected by fluorescence microscopy.The expressions of survivin,MMP-2 and MMP-9 in transfected cells were detected by RT-PCR and Western blot.Results: Survivin ASODN was successfully transfected into MCF-7 cells.After the transfection,RT-PCR and Western blot analysis revealed that the expressions of survivin,MMP-2 and MMP-9 mRNA and their proteins of antisense group were decreased significantly,compared with the control group.Conclusion: The transfection of survivin ASODN could effectively down-regulate the expressions of survivin,MMP-2 and MMP-9 in MCF-7 cell.Survivin ASODN may provide potential gene therapy for breast cancer.
出处 《江苏大学学报(医学版)》 CAS 2011年第3期203-207,277,共6页 Journal of Jiangsu University:Medicine Edition
基金 南通大学自然科学基金资助项目(10Z088) 泰州市311工程人才基金项目(201036)
关键词 生存素 反义寡核苷酸 基质金属蛋白酶-2 基质金属蛋白酶-9 乳腺癌 survivin antisense oligodeoxynucleotide matrix metalloproteinase-2 matrix metalloproteinase-9 breast cancer
  • 相关文献

参考文献13

  • 1恽栋,顾斌,李慧,于鸿.Smad7基因转染人胰腺癌细胞后uPA及PAI-1表达的变化[J].江苏大学学报(医学版),2010,20(6):492-495. 被引量:2
  • 2Vincent Chabottaux,Agnès Noel.Breast cancer progression: insights into multifaceted matrix metalloproteinases[J]. Clinical & Experimental Metastasis . 2007 (8)
  • 3Carrasco RA,Stamm NB,Marcusson E,et al.Antisenseinhibition of survivin expression as a cancer therpeutic. Molecular Cancer Therapeutics . 2011
  • 4Karroum A,Mirshiahi P,Benabbou N,et al.Matrixmetalloproteinase-9 is required for tubular network for-mation and migration of resistant breast cancer cellsMCF-7 through PKC and ERK1/2 signalling pathways. Cancer Letters . 2010
  • 5Coradini,D,Daidone,MG.Biomolecular prognostic factors in breast cancer. Current Opinion in Obstetrics and Gynecology . 2004
  • 6Lee J P,Chang K H,Han J H,et al.Survivin, a novel anti-apoptosis inhibitor, expression in uterine cervical cancer and relationship with prognostic factors. International Journal of Gynecological Cancer . 2005
  • 7Sela B.Survivin: anti-apoptosis protein and a prognostic marker for tumor progression and recurrence. Handchirurgie Mikrochirurgie Plastische Chirurgie . 2002
  • 8Deegan CA,Murray D,Doran P,et al.Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Regional Anesthesia and Pain Medicine . 2010
  • 9Adamkov M,Halasova E,Kajo K,et al.Survivin:a promising biomarker in breast carcinoma. Neoplasma . 2010
  • 10Nandi S,Ulasov IV,Tyler MA,et al.Low-dose radiationenhances survivin-mediated virotherapy against malig-nant glioma stem cells. Cancer Research . 2008

二级参考文献2

共引文献1

同被引文献51

  • 1Adamkov M,Halasova E,Kajo K, et al. Survivin: a promising biomarker in breast carcinoma[J]. Neoplasma, 2010, 57 (6) : 572.
  • 2Carraseo R A, Stamm N B, Mareusson E, et al. Antisense inhibition of survivin expression as a cancer therpeutic [J]. Mol Cancer Ther, 2011, 10(2) : 221.
  • 3Kapellos G, Polonifi K, Farmakis D, et al. Overexpression of survivin levels in circulation and tissue samples of lung cancer patients[J]. Antieancer Res, 2013, 33(8) : 3475.
  • 4Wang K, Chen X, Yan F, et al. 5' - triphosphate - siRNA againt survivin gene induces interferon production and inhibits proliferation of lung cancer cells in vitro[J]. J Immunother, 2013, 36(5): 294.
  • 5Kuroda N, Tanaka A, Sasaki N, et al. Review of renal carcinoma with t (6 ; 11 ) ( q21 ; q12 ) with focus on clinical and pathobiological aspects[J]. Histol Histopathol, 2013, 28 (6) : 685.
  • 6Wade M, Li Y C, Wahl G M. MDM2, MDMX and p53 in oncogenesis and cancer therapy[J]. Nat Rev Cancer, 2013, 13(2) : 83.
  • 7Al Dhaheri Y, Attoub S, Arafat K, et al. Salinomycin induces apoptosis and senescence in breast cancer: upregulation of p21, downregulation of survivin and histone H3 and H4 hyperacetylation [J]. Biochim Biophys Acta, 2013, 1830 (4) : 3121.
  • 8Chen L, Liang L, Yan X, et al. Survivin status affects prognosis and chemosensitivity in epithelial ovarian cancer[J]. Int J Gyneeol Cancer, 2013, 23(2) : 256.
  • 9Phanish MK,Winn SK,Dockrell ME. Connective tissue growth factor-(CTGF,CCN2) -a marker,mediator and therapeutic target for renal fibrosis[J].Nephron Experimental Nephrology,2010,(03):e83-92.
  • 10Dhar A,Ray A. The CCN family proteins in carcinogenesis[J].Experimental Oncology,2010,(01):2-9.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部